Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop
about
Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four casesLiver safety assessment: required data elements and best practices for data collection and standardization in clinical trialsPathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort.Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database.Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control studyDrug induced hepatotoxicity: data from the Serbian pharmacovigilance database.Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymesMechanisms of drug-induced liver injury: from bedside to bench.Losartan-induced Ischemic Hepatocellular Hepatotoxicity: A Case Report and Literature Review.Upper limits of normal for serum alanine aminotransferase levels in Chinese Han population.A challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug?Cholestatic jaundice, acute kidney injury and acute pancreatitis secondary to the recreational use of methandrostenolone: a case report.Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.Lapatinib-induced hepatitis: a case report.Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China.Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported casesFrequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis.Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.Clinical Features of Drug-induced Liver Injury According to Etiology.Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury.A human liver microphysiology platform for investigating physiology, drug safety, and disease modelsDrug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departmentsCharacteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective studyAcute hepatitis E infection accounts for some cases of suspected drug-induced liver injuryPresentation and outcomes with clinically apparent interferon beta hepatotoxicity.Hepatotoxicity due to Clindamycin in Combination with Acetaminophen in a 62-Year-Old African American Female: A Case Report and Review of the Literature.Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis.An Update on Drug-induced Liver Injury.Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.Drug-induced Liver Injury Associated with Mosapride Citrate: A Report of Two Cases.Drug-induced autoimmune-like hepatitis.Drug-induced liver injury: a summary of recent advances.Case definition and phenotype standardization in drug-induced liver injury.Genetic association studies in drug-induced liver injury.
P2860
Q26864098-68B7E0B8-CB25-42A6-B2D5-93138C8879A7Q27006916-5EC75EAF-5773-4115-B0F4-5A026DD042BDQ27690772-51E90830-FD7B-42B7-92E3-C4D7395A0524Q30843946-20B45475-DE77-4A65-A3B6-66B409FAF88DQ30852962-70393521-4C8B-48C0-BAC1-6A14747B4E81Q33558782-38A09EB3-692B-4FC2-A671-ADB23E31CF2FQ33836130-92D90D68-A2FF-4ED0-BC09-B8E70BFFD52AQ34153004-1931FA4B-A249-41B5-9BCB-41C751F53AC5Q34169362-1EEF049E-3D39-424B-A06C-505216FE80C8Q34405954-DB7CE9A6-9145-423D-8434-D24B96802F48Q34409744-0D315D13-7E0A-4DE7-8DE4-1B998E942748Q34660447-069AC795-08B0-405D-A04A-186DCC9645F4Q34818195-A5FC741F-9A89-4B81-BDEE-70339FB33A86Q34848118-6490581E-4F0D-41D7-9DEA-E7765148C666Q34993721-9714344E-3F1B-4292-82EC-2D77CB7AC478Q35526652-DAA0913C-F284-4D06-9A6F-36DB539527A0Q35771883-B2C1CBF7-D40C-41AD-A744-E92DBEB2151EQ36030977-845B6E83-A8EA-4684-A33D-A5CD84A4979CQ36094924-5E2111A7-1F34-41B9-9A96-011360B9A847Q36153978-A6D35E83-3304-481D-A307-18633B726448Q36378839-5BC0398A-DD9F-4D91-9DC7-382392E7D859Q36400550-8EB4575F-10B6-4853-B085-8630290099A9Q36405278-C85D18F8-0632-4E1F-84DA-09ECFF56A480Q36491320-96A2CEF3-217D-464F-919A-0C07C0540089Q36668891-9D0ECA7E-2417-4062-B956-6A8C9FC7C8EEQ36785642-5DEFE434-C847-4BAA-AE35-7B3257F46AF2Q36790141-E27FA18E-13FA-4535-BA78-3CC8F55BF26EQ36845686-66AB7FC1-D36D-4444-94C5-050688495AABQ36906633-9A3AC362-0206-4B19-ACD6-B7E8BF34F12AQ37100592-9F6A011C-FFE8-4FD8-97F1-8A46A148CC24Q37232721-60CE61CB-0E32-4F65-8780-0D7E89694F30Q37613520-D66D2748-4E29-4007-9EEF-47C3D93C1E0CQ37624916-E0140209-8D39-4C61-A132-8354AF833C8AQ37625519-50B03513-45B6-4628-8D98-7409720CF15DQ37636570-9E9A84D7-3513-490E-BAB4-DC4B4A022E2AQ37647432-90CAC59B-F937-43D6-98A8-D99C2B02CB09Q37843783-064629AF-0EBC-42C2-A85A-CF73C7973510Q37867695-6E92C485-4F3B-436B-95E6-5328A89B96D6Q37872195-601328A2-2F69-416C-8E7A-9B7ECCC17E25Q37931275-77EA360F-6912-49ED-B3AA-0EF52D5BA134
P2860
Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Standardization of nomenclatur ...... f a clinical research workshop
@ast
Standardization of nomenclatur ...... f a clinical research workshop
@en
type
label
Standardization of nomenclatur ...... f a clinical research workshop
@ast
Standardization of nomenclatur ...... f a clinical research workshop
@en
prefLabel
Standardization of nomenclatur ...... f a clinical research workshop
@ast
Standardization of nomenclatur ...... f a clinical research workshop
@en
P2093
P2860
P356
P1433
P1476
Standardization of nomenclatur ...... f a clinical research workshop
@en
P2093
Christopher P Day
Einar Björnsson
Jay H Hoofnagle
Jose Serrano
Leonard B Seeff
Raúl J Andrade
Robert J Fontana
P2860
P304
P356
10.1002/HEP.23696
P407
P577
2010-08-01T00:00:00Z